Pmp Medical Products Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.60 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 56.66%
- Profit Growth -3.64%
- Ebitda -293.03%
- Net Worth 1.42%
- Total Assets 5.34%
About Pmp Medical Products
Pmp Medical Products Private Limited (PMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 March 2008 and has a history of 16 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.60 M.
The company currently has active open charges totaling ₹4.00 M.
Naini Todi, Harsh Todi, and Usha Todi serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33111KA2008PTC045819
- Company No.
045819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Mar 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Pmp Medical Products?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naini Todi  | Director | 28-Mar-2008 | Current |
| Harsh Todi | Director | 28-Mar-2008 | Current |
| Usha Todi | Director | 28-Mar-2008 | Current |
Financial Performance of Pmp Medical Products.
Pmp Medical Products Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.66% increase. The company also saw a slight decrease in profitability, with a 3.64% decrease in profit. The company's net worth moved up by a moderate rise of 1.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pmp Medical Products?
In 2019, Pmp Medical Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Sep 2010 | Canara Bank | ₹4.00 M | Open |
How Many Employees Work at Pmp Medical Products?
Unlock and access historical data on people associated with Pmp Medical Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pmp Medical Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pmp Medical Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
